Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Beta Bionics, Inc.

Market Cap 647M 558M 514M 482M 905M 61.19B 914M 6.07B 2.37B 29.97B 2.43B 2.38B 104B P/E Ratio 2026 *
-6.55x
P/E Ratio 2027 * -6.6x
Enterprise Value 473M 408M 375M 352M 662M 44.73B 668M 4.44B 1.73B 21.9B 1.78B 1.74B 75.79B EV / Sales 2026 *
3.54x
EV / Sales 2027 * 3.04x
Free-Float
98.9%
Yield 2026 *
-
Yield 2027 * -
1 day+0.69%
1 week+5.48%
Current month+20.71%
1 month+54.65%
3 months+34.59%
6 months-50.77%
Current year-51.99%
1 week 13.32
Extreme 13.3201
15
1 month 9.03
Extreme 9.03
15
Current year 8.8
Extreme 8.8
32.58
1 year 8.8
Extreme 8.8
32.71
3 years 8.8
Extreme 8.8
32.71
5 years 8.8
Extreme 8.8
32.71
10 years 8.8
Extreme 8.8
32.71
Manager TitleAgeSince
Chief Executive Officer 50 2022-08-14
Director of Finance/CFO 37 2022-07-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 57 2020-01-31
Director/Board Member 62 2025-03-25
Director/Board Member 63 2024-09-30
Date Insider Type Main position Quantity % Market Cap.
06-03Sell

Executive/Senior Manager

-275 0.0006%
06-03Sell

Director

-2,811 0.0063%
06-01Sell

Chief Executive Officer

-16,872 0.0379%
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%+5.48%-24.78% - 647M
+0.55%+0.75%+16.80%-11.58% 174B
+1.00%-0.61%-19.84%+26.74% 146B
+0.08%-1.36%-9.98%-25.65% 127B
-1.26%-4.03%-53.95%-13.42% 69.72B
+0.73%-0.10%+14.62%-6.06% 49.01B
+0.95%+1.72%-24.07%-33.43% 44.74B
-0.15%-2.03%+9.22%+7.23% 36.67B
+0.05%-1.61%+2.79%+33.35% 34.91B
-0.38%+0.74%-10.58%-17.64% 29.65B
Average +0.51%-1.20%-9.98%-4.50% 71.28B
Weighted average by Cap. +0.62%-1.86%-7.36%-4.52%

Financials

2026 *2027 *
Net sales 134M 115M 106M 99.48M 187M 12.63B 189M 1.25B 490M 6.19B 502M 491M 21.41B 181M 156M 143M 135M 253M 17.09B 255M 1.7B 662M 8.37B 678M 664M 28.95B
Net income -99.27M -85.56M -78.75M -73.87M -139M -9.38B -140M -931M -364M -4.59B -373M -365M -15.9B -98.46M -84.86M -78.1M -73.27M -138M -9.3B -139M -923M -361M -4.56B -369M -362M -15.77B
Net Debt -174M -150M -138M -130M -244M -16.47B -246M -1.63B -638M -8.06B -654M -640M -27.9B -97.89M -84.37M -77.65M -72.84M -137M -9.25B -138M -918M -359M -4.53B -367M -360M -15.68B
Logo Beta Bionics, Inc.
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of various solutions to improve the health of insulin-requiring people with diabetes (PWD). The Company's product, the iLet Bionic Pancreas (iLet), is an insulin delivery device cleared by the United States Food and Drug Administration (FDA) to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake. iLet is used for the treatment of Type 1 diabetes (T1D). The Company's solutions include iLet for Adults, iLet for Children, Bionic Circle App and iLet Simulator. The Company is in the early stages of developing an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing, commonly known in the diabetes industry as a patch pump. It is also in the early stages of developing a bihormonal configuration of the iLet.
Employees
422
Date Price Change Volume
26-06-15 14.51 $ -0.14% 274,987
26-06-12 14.53 $ -1.09% 1,328,662
26-06-11 14.69 $ +7.07% 1,515,270
26-06-10 13.72 $ -4.66% 712,896
26-06-09 14.39 $ +3.75% 885,363
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
14.53USD
Average target price
19.18USD
Spread / Average Target
+32.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BBNX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!